Oncotarget #published this #editorial on July 2, 2024 in Volume 15, entitled, “DDX41 and its unique contribution to myeloid leukemogenesis" by Hirotaka Matsui from the Department of Laboratory Medicine, National Cancer Center Hospital, Tokyo, Japan; Department of Medical Oncology and Translational Research, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan. @NationalCancerCenterJapan
#cancer #AML #leukemia #neoplasms #spotlight #trending #openaccess #openscience #peerreview #journal #publication #publishing #meded #research
DOI - doi.org/10.186...
Correspondence to - Hirotaka Matsui - hmatsui@ncc.go.jp
Sign up for free Altmetric alerts about this article - oncotarget.alt...
Subscribe for free publication alerts from Oncotarget - www.oncotarget...
Keywords - cancer, acute myeloid leukemia, DDX41, myelodysplastic neoplasms, myeloid neoplasms with germline predisposition, R-loop
About Oncotarget
Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).
To learn more about Oncotarget, please visit www.oncotarget... and connect with us:
Facebook - / oncotarget
X - / oncotarget
Instagram - / oncotargetjrnl
RU-vid - / @oncotargetjournal
LinkedIn - / oncotarget
Pinterest - / oncotarget
Reddit - / oncotarget
Spotify - open.spotify.c...
Media Contact
MEDIA@IMPACTJOURNALS.COM
18009220957
30 сен 2024
